5AM Venture Management, LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001799883 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: Apr 29, 2020

Total Value: $323M (100.0% shares, 0.0% debt)

Holdings (8)

— Aprea Therapeutics, Inc. 30.7%

Value $99.16M Shares 2,852,654 Est. Cost $45.89 Unrealized —

— Homology Medicines, Inc. 26.6%

Value $86.03M Shares 5,535,919 Est. Cost $20.70 Unrealized —

ARVN Arvinas, Inc. 12.5%

Value $40.3M Shares 1,000,000 Est. Cost $29.28 Unrealized +59.8%

CRNX Crinetics Pharmaceuticals, Inc. 8.5%

Value $27.38M Shares 1,862,286 Est. Cost $19.04 Unrealized +7.7%

CABA Cabaletta Bio, Inc. 8.3%

Value $26.79M Shares 3,669,263 Est. Cost $11.85 Unrealized +15.7%

— scPharmaceuticals Inc. 7.5%

Value $24.07M Shares 3,253,440 Est. Cost $5.66 Unrealized —

IDYA IDEAYA Biosciences, Inc. 4.4%

Value $14.27M Shares 3,463,066 Est. Cost $7.13 Unrealized -0.7%

— Cidara Therapeutics, Inc. 1.5%

Value $4.976M Shares 2,006,511 Est. Cost $3.84 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Aprea Therapeutics, Inc.	2,852,654	$99.16M	30.7%	$45.89	—	COM	03836J102
—	Homology Medicines, Inc.	5,535,919	$86.03M	26.6%	$20.70	—	COM	438083107
ARVN	Arvinas, Inc.	1,000,000	$40.3M	12.5%	$29.28	+59.8%	COM	04335A105
CRNX	Crinetics Pharmaceuticals, Inc.	1,862,286	$27.38M	8.5%	$19.04	+7.7%	COM	22663K107
CABA	Cabaletta Bio, Inc.	3,669,263	$26.79M	8.3%	$11.85	+15.7%	COM	12674W109
—	scPharmaceuticals Inc.	3,253,440	$24.07M	7.5%	$5.66	—	COM	810648105
IDYA	IDEAYA Biosciences, Inc.	3,463,066	$14.27M	4.4%	$7.13	-0.7%	COM	45166A102
—	Cidara Therapeutics, Inc.	2,006,511	$4.976M	1.5%	$3.84	—	COM	171757107